An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus
Jinni Hong,Tingting Fu,Weizhen Liu,Yu Du,Junmin Bu,Guojian Wei,Miao Yu,Yanshan Lin,Cunyun Min,Datao Lin
DOI: https://doi.org/10.2147/dmso.s456173
2024-03-12
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Jinni Hong, 1, 2 Tingting Fu, 1, 2 Weizhen Liu, 1, 2 Yu Du, 1, 2 Junmin Bu, 1, 2 Guojian Wei, 1, 2 Miao Yu, 1, 2 Yanshan Lin, 1, 2 Cunyun Min, 1, 2 Datao Lin 3 1 Department of Traditional Chinese Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, People's Republic of China; 2 Guangdong Provincial Institute of Geriatric, Guangzhou, Guangdong, 510080, People's Republic of China; 3 Department of Parasitology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, People's Republic of China Correspondence: Jinni Hong, Department of Traditional Chinese Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, People's Republic of China, Tel/Fax +86 02083827812, Email Datao Lin, Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, People's Republic of China, Tel/Fax +86 02087330118, Email Ruminococcus gnavus ( R. gnavus) is a gram-positive anaerobe commonly resides in the human gut microbiota. The advent of metagenomics has linked R. gnavus with various diseases, including inflammatory bowel disease (IBD), obesity, and diabetes mellitus (DM), which has become a growing area of investigation. The initial focus of research primarily centered on assessing the abundance of R. gnavus and its potential association with disease presentation, taking into account variations in sample size, sequencing and analysis methods. However, recent investigations have shifted towards elucidating the underlying mechanistic pathways through which R. gnavus may contribute to disease manifestation. In this comprehensive review, we aim to provide an updated synthesis of the current literature on R. gnavus in the context of IBD, obesity, and DM. We critically analyze relevant studies and summarize the potential molecular mediators implicated in the association between R. gnavus and these diseases. Across numerous studies, various molecules such as methylation-controlled J (MCJ), glucopolysaccharides, ursodeoxycholic acid (UDCA), interleukin(IL)-10, IL-17, and capric acid have been proposed as potential contributors to the link between R. gnavus and IBD. Similarly, in the realm of obesity, molecules such as hydrogen peroxide, butyrate, and UDCA have been suggested as potential mediators, while glycine ursodeoxycholic acid (GUDCA) has been implicated in the connection between R. gnavus and DM. Furthermore, it is imperative to emphasize the necessity for additional studies to evaluate the potential efficacy of targeting pathways associated with R. gnavus as a viable strategy for managing these diseases. These findings have significantly expanded our understanding of the functional role of R. gnavus in the context of IBD, obesity, and DM. This review aims to offer updated insights into the role and potential mechanisms of R. gnavus , as well as potential strategies for the treatment of these diseases. Keywords: Ruminococcus gnavus , inflammatory bowel disease, obesity, diabetes mellitus Graphical The human gut microbiota is a complex ecosystem comprising bacteria viruses, fungi and other microbial and eukaryotic species. 1 With bacteria being the predominant taxonomic group, the microbiota comprises around 100 trillion microorganisms, classified into at least 1000 different species. 2 The medicinal fungus Hericium erinaceus as been shown to ameliorate gastrointestinal disorders through modulation of inflammatory processes. 3,4 The gut microbiota grows within the mucin layer and plays a crucial role in maintaining host homeostasis by offering protection to the gut barrier, shaping the immune system, and regulating human metabolism, nutrient absorption, and drug metabolism. 5–9 Perturbations in gut microbiota have been implicated in the development of multiple diseases, including inflammatory bowel disease (IBD), obesity, and diabetes mellitus (DM). 10 In IBD patients, the most prominent changes in the microbiota were the decreased diversity in bacteria species associated with decreased abundance of Bacteroidetes and Firmicutes , 11,12 alongside an increase in the abundance of Proteobacteria . 11 In addition, lower abundance of Faecalibacterium prausnitzii and Roseburia were recorded in patients w -Abstract Truncated-
endocrinology & metabolism